Improving value of care for renal cell carcinoma patients; development of a decision aid for metastatic clear-cell renal cell carcinoma
The use of this tool could contribute to high quality, patient-centered and appropriate care for metastatic clear cell RCC patients in the Netherlands.
Authors
- Harm H.E. van Melick (ORCID: https://orcid.org/0000-0001-9285-0632)
- Mirjam M. Garvelink (ORCID: https://orcid.org/0000-0001-5616-0597)
- P. B. van der Nat (ORCID: https://orcid.org/0000-0002-0990-073X)
- Regina The (ORCID: https://orcid.org/0000-0002-4258-3983)
- Cato Caroline Bresser (ORCID: https://orcid.org/0000-0002-7679-6899)
Institutions
- St. Antonius Ziekenhuis (NL)
- ZorgKeuzeLab (NL)
Publication Details
- Journal
- Patient Education and Counseling
- Published
- 2025-04-29
- DOI
- https://doi.org/10.1016/j.pec.2025.108800
- Primary Topic
- Patient-Provider Communication in Healthcare
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Bristol-Myers Squibb
- Pfizer
- Ipsen Biopharmaceuticals
- Mylan
- Stichting Kwaliteitsgelden Medisch Specialisten
- Ipsen
- Pfizer Pharmaceuticals